JPH0615558B2 - 新規ポリペプチド、その製造法および医薬 - Google Patents

新規ポリペプチド、その製造法および医薬

Info

Publication number
JPH0615558B2
JPH0615558B2 JP58154727A JP15472783A JPH0615558B2 JP H0615558 B2 JPH0615558 B2 JP H0615558B2 JP 58154727 A JP58154727 A JP 58154727A JP 15472783 A JP15472783 A JP 15472783A JP H0615558 B2 JPH0615558 B2 JP H0615558B2
Authority
JP
Japan
Prior art keywords
formula
hydrogen
alkyl
group
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58154727A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5962557A (ja
Inventor
ビルフリ−ト・バウエル
ヤ−ノス・プレス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS5962557A publication Critical patent/JPS5962557A/ja
Publication of JPH0615558B2 publication Critical patent/JPH0615558B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP58154727A 1982-08-24 1983-08-23 新規ポリペプチド、その製造法および医薬 Expired - Lifetime JPH0615558B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH503182A CH655505B (US08067022-20111129-C00003.png) 1982-08-24 1982-08-24
CH5031/82 1982-08-24

Publications (2)

Publication Number Publication Date
JPS5962557A JPS5962557A (ja) 1984-04-10
JPH0615558B2 true JPH0615558B2 (ja) 1994-03-02

Family

ID=4286762

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58154727A Expired - Lifetime JPH0615558B2 (ja) 1982-08-24 1983-08-23 新規ポリペプチド、その製造法および医薬

Country Status (14)

Country Link
US (1) US4496543A (US08067022-20111129-C00003.png)
JP (1) JPH0615558B2 (US08067022-20111129-C00003.png)
AU (1) AU1833383A (US08067022-20111129-C00003.png)
BE (1) BE897546A (US08067022-20111129-C00003.png)
CH (1) CH655505B (US08067022-20111129-C00003.png)
DE (1) DE3328952A1 (US08067022-20111129-C00003.png)
FR (1) FR2532308B1 (US08067022-20111129-C00003.png)
GB (1) GB2125799B (US08067022-20111129-C00003.png)
IL (1) IL69540A0 (US08067022-20111129-C00003.png)
IT (1) IT1169770B (US08067022-20111129-C00003.png)
NL (1) NL8302935A (US08067022-20111129-C00003.png)
PH (1) PH19787A (US08067022-20111129-C00003.png)
SE (1) SE8304573L (US08067022-20111129-C00003.png)
ZA (1) ZA836276B (US08067022-20111129-C00003.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684620A (en) * 1984-09-04 1987-08-04 Gibson-Stephens Neuropharmaceuticals, Inc. Cyclic polypeptides having mu-receptor specificity
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
JPH085913B2 (ja) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド 治療用ソマトスタチン同族体
GR862206B (en) * 1985-09-12 1986-12-31 Univ Tulane Therapeutic somatostatin analogs
US4803261A (en) * 1986-06-27 1989-02-07 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide
US5006510A (en) * 1989-06-20 1991-04-09 Ellis Wladislaw V Method for relieving chronic pain with a somatostatin analog composition
JP3227673B2 (ja) * 1992-06-19 2001-11-12 味の素株式会社 膵炎予防治療薬
US6184208B1 (en) 1994-06-29 2001-02-06 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235886A (en) * 1979-10-31 1980-11-25 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
DE3062075D1 (en) * 1979-11-27 1983-03-24 Sandoz Ag Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
US4328135A (en) * 1980-06-13 1982-05-04 American Home Products Corporation Octapeptides lowering growth hormone
US4282143A (en) * 1980-06-13 1981-08-04 American Home Products Corporation Octapeptides lowering growth hormone
DK81082A (da) * 1981-03-06 1982-09-07 Sandoz Ag Fremgangsmaade til fremstilling af polypeptider
US4360516A (en) * 1981-04-13 1982-11-23 Merck & Co., Inc. Modified D-retro cyclic hexapeptide somatostatin analogs

Also Published As

Publication number Publication date
DE3328952A1 (de) 1984-03-01
US4496543A (en) 1985-01-29
NL8302935A (nl) 1984-03-16
IT8322612A0 (it) 1983-08-23
FR2532308B1 (fr) 1987-09-11
GB2125799B (en) 1985-09-11
SE8304573D0 (sv) 1983-08-23
JPS5962557A (ja) 1984-04-10
BE897546A (fr) 1984-02-17
GB8322529D0 (en) 1983-09-21
PH19787A (en) 1986-07-02
IT1169770B (it) 1987-06-03
SE8304573L (sv) 1984-02-25
CH655505B (US08067022-20111129-C00003.png) 1986-04-30
GB2125799A (en) 1984-03-14
ZA836276B (en) 1985-04-24
IL69540A0 (en) 1983-11-30
FR2532308A1 (fr) 1984-03-02
AU1833383A (en) 1984-03-01

Similar Documents

Publication Publication Date Title
US4328214A (en) Cyclopeptides and pharmaceutical preparations thereof and also processes for their manufacture
US4395403A (en) Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
DE3853384T2 (de) Peptid.
US4435385A (en) N-Acyl-polypeptides and processes for the production thereof
JPS61293997A (ja) 生活性リジン含有オクタペプチド及びその調整方法
US4191754A (en) Bicyclic somatostatin analogs
US4505897A (en) Cyclic pentapeptides displaying somatostatin antagonism and method of treatment of mammals therewith
JP2003525864A (ja) 共有結合で架橋されたインスリンダイマー
US4603120A (en) Cyclic octapeptides and pharmaceutical preparations thereof, as well as processes for their manufacture, and their use
EP0031303A2 (de) Cyclooctapeptide und pharmazeutische Präparate davon, sowie Verfahren zur Herstellung derselben und ihre Anwendung
JPS6218560B2 (US08067022-20111129-C00003.png)
US4190648A (en) Peptides having somatostatin activity
US4261885A (en) Novel somatostatin analogue
JPH0273100A (ja) 医薬用化合物
KR100629013B1 (ko) Ｉｇｆ-ⅰ 및 -ⅱ를 억제하는 ｇｈ-ｒｈ의 길항 유사체
JP2729498B2 (ja) ヒトインシユリンアナログ類
DK146623B (da) Fremgangsmaade til fremstilling af bifunktionelt tvaerbundet insulin
JPH0615558B2 (ja) 新規ポリペプチド、その製造法および医薬
EP0283956B1 (en) Fluorine containing atrial natriuretic peptides
US4405607A (en) Novel pentapeptides, processes for their production, pharmaceutical compositions comprising said pentapeptides and their use
EP0117447B1 (de) Cyclische Peptide mit Somatostatin-Wirkung
DE2804566A1 (de) Polypeptide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2628006C2 (de) Tridecapeptid, Verfahren zu seiner Herstellung und seine Verwendung
JPH0363559B2 (US08067022-20111129-C00003.png)
US4530837A (en) Peptide derivatives, their preparation process and their pharmaceutical use